Related Experiment Video

Updated: Sep 18, 2025

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.5K

From Research to Practice: The Future of Cardiovascular Care

Prabhash C Manoria1

  • 1Cardiology, Director of Manoria Heart and Critical Care Hospital, Bhopal, IND.

Cureus
|June 20, 2025
PubMed

Insights

Advancements in genomics, AI, and regenerative medicine are revolutionizing cardiovascular disease care. These innovations promise precision medicine, early detection, and personalized therapies for better patient outcomes.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Genomics

Background:

  • Cardiovascular diseases (CVDs) are the primary global cause of mortality.
  • Continuous research and clinical advancements are crucial for managing CVDs.

Purpose of the Study:

  • To review key innovations transforming cardiovascular care.
  • To explore the translation of research into clinical practice.
  • To highlight advancements in precision medicine, early detection, and personalized therapies.

Main Methods:

  • Literature review of recent breakthroughs in genomics, AI, wearable technology, and regenerative medicine.
  • Analysis of innovations bridging research and clinical application.
  • Discussion of implementation challenges and future directions.

Main Results:

  • Genomics, AI, wearable technology, and regenerative medicine are reshaping cardiovascular care.
  • These innovations facilitate precision medicine, early detection, and personalized treatment strategies.
  • Implementation challenges exist but future directions aim to optimize CV outcomes.

Conclusions:

  • Emerging technologies are pivotal in advancing cardiovascular medicine.
  • Translating research innovations into clinical practice is key to improving patient outcomes.
  • Addressing implementation challenges is essential for the future of cardiovascular care.

Keywords:
artificial intelligencecardiovascular diseasegenomicsstem cellswearables

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions06:18

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions

Published on: April 5, 2024

1.2K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
34
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.0K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
353